Most-Read HIV News of 2021
In 2021, readers were interested in the first mRNA vaccine trial for HIV, an increase in funding for an initiative to end HIV, and more.
5 developments to watch for in HIV/AIDS treatment and prevention in 2021
Injectable treatments may start to replace daily pills.
CRISPR Gene-Editing Shows Promise Against HIV
New research by shows how one of the major scientific breakthroughs of recent years might be used to eliminate HIV infection.
One HIV Vaccine Fails While a First-of-its-Kind mRNA Vaccine Trial is Set to Begin
Johnson & Johnson’s experimental HIV vaccine, which uses the same technology as its COVID-19 vaccine, was found to not be effective at preventing infection.
Biden Budget Proposes Increased Funding for Ending HIV, But Not for Hepatitis Programs
Biden is proposing a $46 million increase to the Ryan White HIV/AIDS Programs and $20 million for HUD’s Housing Opportunities for Persons with AIDS program. However, no increases were planned for hepatitis programs.
Extended Study Follow-up Highlights Need for Improved Support for Engaging Those Who Inject Drugs Living With HIV in Treatment
The researchers suggest that additional support may be needed to ensure continuous and potentially increased use of antiretroviral treatment and medication for opioid use disorders and subsequent viral suppression.
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
